We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Comprehensive Study of COVID-19 Detection Tools and Technologies to Help Develop Low-Cost Device for Use by Anyone, Anywhere

By LabMedica International staff writers
Posted on 17 Jun 2021
A team of researchers has sifted through hundreds of research papers for determining the COVID-19 detection tools and technologies that best detect the virus in order to help develop a low-cost device for use by anyone, anywhere.

A team of researchers led by engineers at Concordia University (Montreal, Canada) have combed the growing pile of literature on COVID-19 tools and techniques. More...
Clinical research on COVID-19 has boomed in the 18 months since the disease first appeared. Countless papers have looked at the topic from almost every possible angle, including methods of detection. The team wanted to categorize and understand what exists, what is lacking and what can be improved. The result was a thorough assessment of the field citing almost 600 separate papers that cover an extensive body of literature. The researchers believe that their new paper published in the journal Clinical Microbiology Reviews provides a rich “one-stop shop” resource for people interested in the topic, including experts in clinical microbiology and non-experts who want to know more about different methods.

The researchers point out that the explosion of detection techniques and tools - some of questionable quality - came from the need to expand testing rapidly while supply chains were disrupted by the virus’s global spread. Some techniques are more accurate; others are more affordable. Some require sophisticated lab equipment; others do not. The World Health Organization’s internationally recognized ASSURED criteria for point-of-care diagnostic devices helped them assess the various tests being used. The acronym stands for affordable, sensitive, specific, user-friendly, rapid and robust, equipment-free and deliverable to end users. This helped the researchers determine the strengths and weaknesses of the existing diagnostic tools.

According to the researchers, the most effective tools in use now are nucleic acid amplification tests, which are highly effective at detecting ribonucleic acid (RNA). The researchers hope that identifying current weaknesses in our diagnostic tools will help avoid the need of adopting drastic measures like lockdowns and shuttering the economy when the next pandemic emerges.

“Our study looks at these technologies’ performance characteristics, their challenges and the gaps in our current knowledge and future directions,” said the study’s primary investigator and lead author Hamid Tali, a PhD student in the Department of Chemical and Materials Engineering. “We describe the lessons learned throughout the pandemic on the diagnostics of this virus, which will be helpful in the case of a future pandemic. We hope that this will help guide researchers toward an ideal device that can be used by anyone, anywhere at a very low cost.”

Related Links:
Concordia University


Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Online QC Software
Acusera 24•7
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Molecular Diagnostics

view channel
Image: The two new tests are used with the LightCycler 480 and LightCycler PRO instruments (Photo courtesy of Roche)

New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance

Cyclospora cayetanensis, a food- and waterborne intestinal parasite, can cause prolonged diarrhea, fatigue, and abdominal cramping, placing added strain on urgent care and emergency departments during outbreaks.... Read more

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.